Green Thumb Industries (GTBIF) Equity Average (2019 - 2026)
Green Thumb Industries (GTBIF) reported Equity Average of $1.9 billion for Q1 2026, up 5.9% on a YoY basis from $1.8 billion in Q1 2025, and up 1.66% quarter-over-quarter from $1.9 billion in Q4 2025.
Green Thumb Industries (GTBIF) Equity Average (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Equity Average for 8 years, with the latest figure at $1.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 5.9% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 5.9% YoY), and the FY2025 full-year result was $1.8 billion, up 5.94% from the prior year.
- Equity Average for Q1 2026 stood at $1.9 billion, up from $1.9 billion in the prior quarter.
- The five-year high for Equity Average was $1.9 billion in Q1 2026, with the low at $1.6 billion in Q1 2022.
- Historically, Equity Average has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2024.
- Annual changes were most pronounced in 2022 — Equity Average jumped 62.35% — and 2023, when it rose 0.53%.
- Green Thumb Industries' Equity Average stood at $1.7 billion in 2022, then advanced by 1.12% to $1.7 billion in 2023, then advanced by 4.51% to $1.8 billion in 2024, then grew by 5.1% to $1.9 billion in 2025, then climbed by 1.66% to $1.9 billion in 2026.
- The last three Equity Average figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 1.90 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Bn |
| Dec 31, 2025 | 1.87 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.80 Bn |
| Mar 31, 2025 | 1.80 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 1.75 Bn |
| Mar 31, 2024 | 1.73 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | 1.71 Bn |
| Jun 30, 2023 | 1.69 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.69 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.67 Bn |
| Mar 31, 2022 | 1.64 Bn |
| Dec 31, 2021 | 1.53 Bn |
| Sep 30, 2021 | 1.34 Bn |
| Jun 30, 2021 | 1.17 Bn |